Alembic Pharmaceuticals Limited’s cover photo
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Pharmaceutical Manufacturing

Vadodara, Gujarat 339,067 followers

Touching lives beyond healthcare

About us

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Industry
Pharmaceutical Manufacturing
Company size
5,001-10,000 employees
Headquarters
Vadodara, Gujarat
Type
Public Company
Founded
1907

Locations

Employees at Alembic Pharmaceuticals Limited

Updates

  • 𝐖𝐨𝐫𝐥𝐝 𝐊𝐢𝐝𝐧𝐞𝐲 𝐃𝐚𝐲 𝟐𝟎𝟐𝟓: 𝐓𝐚𝐤𝐞 𝐭𝐡𝐞 𝐭𝐞𝐬𝐭, 𝐩𝐫𝐨𝐭𝐞𝐜𝐭 𝐲𝐨𝐮𝐫 𝐤𝐢𝐝𝐧𝐞𝐲𝐬 Chronic Kidney Disease (CKD) often goes unnoticed until it reaches an advanced stage. With 13% of Indians affected and cases increasing, early detection is crucial. Certain factors increase the risk of CKD, including diabetes, high blood pressure, heart disease, and a family history of kidney disease. Timely screening is essential. Blood and urine tests can help detect CKD early and protect kidney health. If you have diabetes or hypertension, consult your doctor about kidney screening without delay. Detect early, protect kidney health! #AlembicPharmaceuticals #WorldKidneyDay #CKDAwareness #KidneyHealth Source: Talukdar R et al. Nephrology (Carlton). 2025 Jan;30(1):e14420.

  • 𝐓𝐡𝐢𝐬 𝐖𝐨𝐫𝐥𝐝 𝐆𝐥𝐚𝐮𝐜𝐨𝐦𝐚 𝐖𝐞𝐞𝐤, 𝐥𝐞𝐭’𝐬 𝐟𝐨𝐜𝐮𝐬 𝐨𝐧 𝐩𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐧𝐠 𝐯𝐢𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐚 𝐛𝐫𝐢𝐠𝐡𝐭𝐞𝐫 𝐟𝐮𝐭𝐮𝐫𝐞! Glaucoma is a group of eye diseases that gradually damage the optic nerve, leading to irreversible vision loss. It affects 1.12 crore Indians, yet 90% remain undiagnosed, as it shows no symptoms in the early stages. Without timely detection, glaucoma silently progresses, impacting productivity, social interactions, and overall well-being. At Alembic, we are committed to raising awareness and advancing early detection to protect vision and prevent glaucoma-related blindness. With awareness and action, we can help preserve sight for generations to come. #AlembicPharmaceuticals #WorldGlaucomaWeek #EyeHealth Sources: 1. Praveen Kumar Seth et al. Prevalence of glaucoma types, clinical profile and disease severity at presentation: Tertiary Institute based cross-sectional study from South India, IJO, Vol 71, Issue 10, 3306-3312. 2. Rewri P. Towards better management of glaucoma in India. Indian J Ophthalmol. 2023 Mar;71(3):686-688.

  • 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐖𝐨𝐦𝐞𝐧 𝐖𝐡𝐨 𝐌𝐚𝐤𝐞 𝐀𝐥𝐞𝐦𝐛𝐢𝐜 𝐒𝐭𝐫𝐨𝐧𝐠𝐞𝐫! At Alembic, we recognize that our women employees are an important pillar of our success – bringing dedication, passion, and excellence to everything they do. This year’s Women’s Day celebration was a special way for us to acknowledge their hard work, resilience, and contributions, not just within our organization but in every sphere of life. The event was filled with laughter, togetherness, and appreciation, reflecting Alembic’s ongoing commitment to creating a workplace where women feel valued, supported, and empowered. Through women-centric policies, opportunities for growth, and a culture that champions inclusivity, we strive to make a meaningful difference in their professional and personal journeys. This celebration was just one of the many ways we express our gratitude to our female colleagues and we look forward to continuing to create a stronger, more inclusive future together! #AlembicPharmaceuticals #AlembicCares #InternationalWomensDay2025 #IWD2025

    • No alternative text description for this image
  • 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐟𝐨𝐫 𝐀𝐥𝐥 – 𝐀𝐥𝐞𝐦𝐛𝐢𝐜’𝐬 𝙎𝙬𝙖𝙨𝙩𝙝𝙮𝙖 𝙎𝙚𝙩𝙪 & 𝙎𝙪𝙥𝙤𝙨𝙝𝙖𝙣 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞𝐬 At Alembic, we believe access to quality healthcare is a fundamental right. We are committed to driving positive change by making healthcare accessible to the most vulnerable communities. Through 𝙎𝙬𝙖𝙨𝙩𝙝𝙮𝙖 𝙎𝙚𝙩𝙪, we 𝐛𝐫𝐢𝐝𝐠𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐠𝐚𝐩𝐬, ensuring curative care reaches those in need. Beyond accessibility, we also focus on 𝐞𝐚𝐫𝐥𝐲 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, proactively addressing critical health concerns. Our 𝙎𝙪𝙥𝙤𝙨𝙝𝙖𝙣 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲 tackles 𝗺𝗮𝗹𝗻𝘂𝘁𝗿𝗶𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗮𝗻𝗮𝗲𝗺𝗶𝗮, ensuring children’s well-being. We also 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 𝗴𝗿𝗮𝘀𝘀𝗿𝗼𝗼𝘁𝘀 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 by aiding needed infrastructure development and training of frontline service delivery professionals to better support child and maternal health. Alembic remains dedicated to 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 through both innovative medicines and sustainable community-driven initiatives – building a 𝗵𝗲𝗮𝗹𝘁𝗵𝗶𝗲𝗿, 𝘀𝘁𝗿𝗼𝗻𝗴𝗲𝗿 𝗳𝘂𝘁𝘂𝗿𝗲 for all. #AlembicPharmaceuticals #CSRImpact #HealthcareForAll

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • #GPTW #alembic #alembicpharmaceutical for the 3rd consecutive year, we have been certified as a great place to work.

    View organization page for Alembic Pharmaceuticals Limited

    339,067 followers

    🏆 𝗚𝗿𝗲𝗮𝘁 𝗣𝗹𝗮𝗰𝗲 𝘁𝗼 𝗪𝗼𝗿𝗸® - 𝗕𝗲𝗰𝗮𝘂𝘀𝗲 𝗼𝗳 𝗢𝘂𝗿 𝗣𝗲𝗼𝗽𝗹𝗲! For the third consecutive year, we have been certified as a Great Place to Work®! This milestone is a testament to the integrity, collaboration, and resilience that define our Alembians, every day. To every Alembian - thank you! Let’s continue shaping a workplace where excellence and a people-first culture thrive. 🚀 #GPTW #3YearsStrong #ProudAlembian #WorkplaceExcellence #PeopleFirst #LifeAtAlembic #AlembicPharmaceuticals

    • No alternative text description for this image
  • 🏆 𝗚𝗿𝗲𝗮𝘁 𝗣𝗹𝗮𝗰𝗲 𝘁𝗼 𝗪𝗼𝗿𝗸® - 𝗕𝗲𝗰𝗮𝘂𝘀𝗲 𝗼𝗳 𝗢𝘂𝗿 𝗣𝗲𝗼𝗽𝗹𝗲! For the third consecutive year, we have been certified as a Great Place to Work®! This milestone is a testament to the integrity, collaboration, and resilience that define our Alembians, every day. To every Alembian - thank you! Let’s continue shaping a workplace where excellence and a people-first culture thrive. 🚀 #GPTW #3YearsStrong #ProudAlembian #WorkplaceExcellence #PeopleFirst #LifeAtAlembic #AlembicPharmaceuticals

    • No alternative text description for this image
  • We are delighted to share that our Chief Human Resources Officer, Namita Patwari, participated in The Great Connect, hosted by Great Place to Work® Institute (India) in Ahmedabad earlier today. The discussion was centered around 'critical leadership behaviours that drive employee retention' and proved fruitful, with valuable insights shared by all panellists. At Alembic, we are committed to fostering a positive and inclusive work environment where our employees thrive. We believe that strong leadership and a focus on employee well-being are essential for sustained success. #AlembicPharmaceuticals #GreatPlaceToWork #Leadership #EmployeeRetention

    • Namita Patwari, CHRO, Alembic Pharmaceuticals Ltd.

Similar pages

Browse jobs